No CrossRef data available.
Article contents
Length of antibiotic therapy among adults hospitalized with uncomplicated community-acquired pneumonia, 2013–2020
Published online by Cambridge University Press: 14 February 2024
Abstract
Objective:
The 2014 US National Strategy for Combating Antibiotic-Resistant Bacteria (CARB) aimed to reduce inappropriate inpatient antibiotic use by 20% for monitored conditions, such as community-acquired pneumonia (CAP), by 2020. We evaluated annual trends in length of therapy (LOT) in adults hospitalized with uncomplicated CAP from 2013 through 2020.
Methods:
We conducted a retrospective cohort study among adults with a primary diagnosis of bacterial or unspecified pneumonia using International Classification of Diseases Ninth and Tenth Revision codes in MarketScan and the Centers for Medicare & Medicaid Services databases. We included patients with length of stay (LOS) of 2–10 days, discharged home with self-care, and not rehospitalized in the 3 days following discharge. We estimated inpatient LOT based on LOS from the PINC AI Healthcare Database. The total LOT was calculated by summing estimated inpatient LOT and actual postdischarge LOT. We examined trends from 2013 to 2020 in patients with total LOT >7 days, which was considered an indicator of likely excessive LOT.
Results:
There were 44,976 and 400,928 uncomplicated CAP hospitalizations among patients aged 18–64 years and ≥65 years, respectively. From 2013 to 2020, the proportion of patients with total LOT >7 days decreased by 25% (68% to 51%) among patients aged 18–64 years and by 27% (68%–50%) among patients aged ≥65 years.
Conclusions:
Although likely excessive LOT for uncomplicated CAP patients decreased since 2013, the proportion of patients treated with LOT >7 days still exceeded 50% in 2020. Antibiotic stewardship programs should continue to pursue interventions to reduce likely excessive LOT for common infections.
- Type
- Original Article
- Information
- Creative Commons
- This is a work of the US Government and is not subject to copyright protection within the United States. To the extent this work is subject to copyright outside of the United States, the US Government retains a paidup, nonexclusive, irrevocable worldwide licence to reproduce, prepare derivative works, distribute copies to the public and display publicly the Contribution, and to permit others to do so. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America.
- Copyright
- © The Society for Healthcare Epidemiology of America, 2024
Footnotes
PREVIOUS PRESENTATION. A portion of the findings in this manuscript were presented as abstracts from SHEA 2023 and IDWeek 2022.
References
US National Strategy for Combating Antibiotic-Resistant Bacteria (national strategy). Centers for Disease Control and Prevention website. https://www.cdc.gov/drugresistance/us-activities/national-strategy.html. Published 2014. Accessed March 21, 2023.Google Scholar
Vital signs: improving antibiotic use among hospitalized patients. Morb Mortal Wkly Rep 2014;63:194–200.Google Scholar
Core elements of hospital antibiotic stewardship programs. Centers for Disease Control and Prevention website. https://www.cdc.gov/antibiotic-use/core-elements/hospital.html. Published 2019. Accessed July 11, 2023.Google Scholar
Mandell, LA, Wunderink, RG, Anzueto, A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44 suppl 2:S27–S72.CrossRefGoogle Scholar
Metlay, JP, Waterer, GW, Long, AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia: an official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med 2019;200:e45–e67.CrossRefGoogle ScholarPubMed
Yi, SH, Hatfield, KM, Baggs, J, et al. Duration of antibiotic use among adults with uncomplicated community-acquired pneumonia requiring hospitalization in the United States. Clin Infect Dis 2018;66:1333–1341.CrossRefGoogle ScholarPubMed
Magill, SS, O’Leary, E, Ray, SM, et al. Assessment of the appropriateness of antimicrobial use in US hospitals. JAMA Netw Open 2021;4:e212007.CrossRefGoogle ScholarPubMed
Vaughn, VM, Flanders, SA, Snyder, A, et al. Excess antibiotic treatment duration and adverse events in patients hospitalized with pneumonia: a multihospital cohort study. Ann Intern Med 2019;171:153–163.CrossRefGoogle ScholarPubMed
Curran, J, Lo, J, Leung, V, et al. Estimating daily antibiotic harms: an umbrella review with individual study meta-analysis. Clin Microbiol Infect 2022;28:479–490.CrossRefGoogle ScholarPubMed
Avdic, E, Cushinotto, LA, Hughes, AH, et al. Impact of an antimicrobial stewardship intervention on shortening the duration of therapy for community-acquired pneumonia. Clin Infect Dis 2012;54:1581–1587.CrossRefGoogle ScholarPubMed
Li, DX, Ferrada, MA, Avdic, E, Tamma, PD, Cosgrove, SE, et al. Sustained impact of an antibiotic stewardship intervention for community-acquired pneumonia. Infect Control Hosp Epidemiol 2016;37:1243–1236.CrossRefGoogle ScholarPubMed
Foolad, F, Huang, AM, Nguyen, CT, et al. A multicentre stewardship initiative to decrease excessive duration of antibiotic therapy for the treatment of community-acquired pneumonia. J Antimicrob Chemother 2018;73:1402–1407.CrossRefGoogle ScholarPubMed
Uranga, A, España, PP, Bilbao, A, et al. Duration of antibiotic treatment in community-acquired pneumonia: a multicenter randomized clinical trial. JAMA Intern Med 2016;176:1257–1265.CrossRefGoogle ScholarPubMed
van den Bergh, D, Messina, AP, Goff, DA, et al. A pharmacist-led prospective antibiotic stewardship intervention improves compliance to community-acquired pneumonia guidelines in 39 public and private hospitals across South Africa. Int J Antimicrob Agents 2020;56:106189.CrossRefGoogle ScholarPubMed
Madaras-Kelly, KJ, Burk, M, Caplinger, C, et al. Total duration of antimicrobial therapy in veterans hospitalized with uncomplicated pneumonia: results of a national medication utilization evaluation. J Hosp Med 2016;11:832–839.CrossRefGoogle ScholarPubMed
Scarpato, SJ, Timko, DR, Cluzet, VC, et al. An evaluation of antibiotic prescribing practices upon hospital discharge. Infect Control Hosp Epidemiol 2017;38:353–355.CrossRefGoogle ScholarPubMed
Giesler, DL, Krein, S, Brancaccio, A, et al. Reducing overuse of antibiotics at discharge home: a single-center mixed-methods pilot study. Am J Infect Control 2022;50:777–786.CrossRefGoogle Scholar
Vaughn, VM, Ratz, D, Greene, MT, et al. Antibiotic stewardship strategies and their association with antibiotic overuse after hospital discharge: an analysis of the reducing overuse of antibiotics at discharge (road) home framework. Clin Infect Dis 2022;75:1063–1072.CrossRefGoogle ScholarPubMed
Mercuro, NJ, Medler, CJ, Kenney, RM, et al. Pharmacist-driven transitions of care practice model for prescribing oral antimicrobials at hospital discharge. JAMA Netw Open 2022;5:e2211331.CrossRefGoogle ScholarPubMed
Antimicrobial stewardship transition of care. Henry Ford website. https://www.henryford.com/hcp/academic/ams-toc. Accessed July 11, 2023.Google Scholar
Whittle, J, Fine, MJ, Joyce, DZ, et al. Community-acquired pneumonia: can it be defined with claims data? Am J Med Qual 1997;12:187–93.CrossRefGoogle ScholarPubMed
Smithee, RB, Markus, TM, Soda, E, et al. Pneumonia hospitalization coding changes associated with transition from the 9th to 10th revision of International Classification of Diseases.
Health Serv Res Manag Epidemiol 2020;7:2333392820939801.Google ScholarPubMed
McCarthy et al. supplementary material
McCarthy et al. supplementary material
File
209.2 KB